Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1513 | 2617 | 23.4 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
98 | 3 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY | 75394 |
93 | 2 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION | 26351 |
1513 | 1 | CYCLOSPORINE//C 2 MONITORING//NEORAL | 2617 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYCLOSPORINE | authKW | 428258 | 13% | 11% | 344 |
2 | C 2 MONITORING | authKW | 287456 | 1% | 79% | 31 |
3 | NEORAL | authKW | 259682 | 1% | 70% | 32 |
4 | TRANSPLANTATION PROCEEDINGS | journal | 214560 | 33% | 2% | 855 |
5 | TRANSPLANTATION | WoSSC | 140589 | 48% | 1% | 1257 |
6 | THERAPEUTIC DRUG MONITORING | journal | 80874 | 6% | 4% | 161 |
7 | CYCLOSPORINE G | authKW | 72684 | 0% | 69% | 9 |
8 | CYCLOSPORINE A | authKW | 65969 | 4% | 5% | 106 |
9 | CYCLOSPORINE MONITORING | authKW | 63513 | 0% | 78% | 7 |
10 | CYCLOSPORIN | authKW | 60137 | 2% | 8% | 65 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 140589 | 48% | 1% | 1257 |
2 | Immunology | 20507 | 43% | 0% | 1115 |
3 | Surgery | 19088 | 46% | 0% | 1198 |
4 | Medical Laboratory Technology | 13857 | 12% | 0% | 320 |
5 | Pharmacology & Pharmacy | 5802 | 29% | 0% | 754 |
6 | Toxicology | 1333 | 7% | 0% | 195 |
7 | Urology & Nephrology | 542 | 5% | 0% | 129 |
8 | Chemistry, Analytical | 56 | 4% | 0% | 94 |
9 | Biochemical Research Methods | 24 | 2% | 0% | 53 |
10 | Pediatrics | 18 | 2% | 0% | 52 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN S210622 | 23333 | 0% | 100% | 2 |
2 | HLTH TRANSPLANTAT | 23333 | 0% | 100% | 2 |
3 | IMMUNOL HAEMATOL ONCOL BONE MARROW TRANSPLA | 15554 | 0% | 67% | 2 |
4 | ANALYT UNIT | 15391 | 0% | 11% | 12 |
5 | TRANSPLANT IMMUNOL INNOVAT ANTIREJECT THER | 13121 | 0% | 38% | 3 |
6 | ABDOMINABLE TRANSPLANTAT SURG | 11666 | 0% | 100% | 1 |
7 | AFFILIATED HOSP 3SHANXI PROV PEOPLES HOSP | 11666 | 0% | 100% | 1 |
8 | ALLOGENEIC STEM CELL TRANSPLANTAT B87 | 11666 | 0% | 100% | 1 |
9 | ANAL MODULO FISIOPATOL RENALE | 11666 | 0% | 100% | 1 |
10 | BALDI RIBERI CLIN | 11666 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION PROCEEDINGS | 214560 | 33% | 2% | 855 |
2 | THERAPEUTIC DRUG MONITORING | 80874 | 6% | 4% | 161 |
3 | TRANSPLANTATION | 23956 | 7% | 1% | 195 |
4 | CLINICAL TRANSPLANTATION | 8748 | 2% | 1% | 53 |
5 | CLINICAL CHEMISTRY | 7039 | 3% | 1% | 85 |
6 | CLINICAL PHARMACOKINETICS | 4710 | 1% | 1% | 31 |
7 | TRANSPLANT INTERNATIONAL | 4335 | 1% | 1% | 34 |
8 | CLINICAL BIOCHEMISTRY | 2575 | 1% | 1% | 34 |
9 | PROGRESS IN ALLERGY | 2534 | 0% | 4% | 6 |
10 | THERAPIE | 1988 | 1% | 1% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLOSPORINE | 428258 | 13% | 11% | 344 | Search CYCLOSPORINE | Search CYCLOSPORINE |
2 | C 2 MONITORING | 287456 | 1% | 79% | 31 | Search C+2+MONITORING | Search C+2+MONITORING |
3 | NEORAL | 259682 | 1% | 70% | 32 | Search NEORAL | Search NEORAL |
4 | CYCLOSPORINE G | 72684 | 0% | 69% | 9 | Search CYCLOSPORINE+G | Search CYCLOSPORINE+G |
5 | CYCLOSPORINE A | 65969 | 4% | 5% | 106 | Search CYCLOSPORINE+A | Search CYCLOSPORINE+A |
6 | CYCLOSPORINE MONITORING | 63513 | 0% | 78% | 7 | Search CYCLOSPORINE+MONITORING | Search CYCLOSPORINE+MONITORING |
7 | CYCLOSPORIN | 60137 | 2% | 8% | 65 | Search CYCLOSPORIN | Search CYCLOSPORIN |
8 | SANDIMMUNE | 58331 | 0% | 100% | 5 | Search SANDIMMUNE | Search SANDIMMUNE |
9 | CYCLOSPORINE METABOLITES | 48608 | 0% | 83% | 5 | Search CYCLOSPORINE+METABOLITES | Search CYCLOSPORINE+METABOLITES |
10 | ERYTHROCYTE TO PLASMA DISTRIBUTION | 46665 | 0% | 100% | 4 | Search ERYTHROCYTE+TO+PLASMA+DISTRIBUTION | Search ERYTHROCYTE+TO+PLASMA+DISTRIBUTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TAFAZOLI, A , (2015) CYCLOSPORINE USE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: PHARMACOKINETIC APPROACH.IMMUNOTHERAPY. VOL. 7. ISSUE 7. P. 811 -836 | 109 | 64% | 0 |
2 | FAHR, A , (1993) CYCLOSPORINE CLINICAL PHARMACOKINETICS.CLINICAL PHARMACOKINETICS. VOL. 24. ISSUE 6. P. 472-495 | 113 | 76% | 244 |
3 | CHRISTIANS, U , SEWING, KF , (1993) CYCLOSPORINE METABOLISM IN TRANSPLANT PATIENTS.PHARMACOLOGY & THERAPEUTICS. VOL. 57. ISSUE 2-3. P. 291-345 | 162 | 59% | 113 |
4 | JORGA, A , HOLT, DW , JOHNSTON, A , (2004) THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE.TRANSPLANTATION PROCEEDINGS. VOL. 36. ISSUE 2. P. 396S-403S | 76 | 95% | 24 |
5 | KIVISTO, KT , (1992) A REVIEW OF ASSAY-METHODS FOR CYCLOSPORINE - CLINICAL IMPLICATIONS.CLINICAL PHARMACOKINETICS. VOL. 23. ISSUE 3. P. 173-190 | 122 | 89% | 31 |
6 | HOLT, DW , JOHNSTON, A , ROBERTS, NB , TREDGER, JM , TRULL, AK , (1994) METHODOLOGICAL AND CLINICAL ASPECTS OF CYCLOSPORINE MONITORING - REPORT OF THE ASSOCIATION OF CLINICAL BIOCHEMISTS TASK-FORCE.ANNALS OF CLINICAL BIOCHEMISTRY. VOL. 31. ISSUE . P. 420-446 | 105 | 85% | 49 |
7 | DAVID, OJ , JOHNSTON, A , (2001) LIMITED SAMPLING STRATEGIES FOR ESTIMATING CYCLOSPORIN AREA UNDER THE CONCENTRATION-TIME CURVE: REVIEW OF CURRENT ALGORITHMS.THERAPEUTIC DRUG MONITORING. VOL. 23. ISSUE 2. P. 100-114 | 72 | 90% | 79 |
8 | LINDHOLM, A , (1991) FACTORS INFLUENCING THE PHARMACOKINETICS OF CYCLOSPORINE IN MAN.THERAPEUTIC DRUG MONITORING. VOL. 13. ISSUE 6. P. 465-477 | 96 | 85% | 128 |
9 | MONCHAUD, C , MARQUET, P , (2009) PHARMACOKINETIC OPTIMIZATION OF IMMUNOSUPPRESSIVE THERAPY IN THORACIC TRANSPLANTATION: PART I.CLINICAL PHARMACOKINETICS. VOL. 48. ISSUE 7. P. 419-462 | 72 | 67% | 22 |
10 | MARCEN, R , VILLAFRUELA, JJ , (2005) CICLOSPORINE DOSE MOITORIZATION IN RENAL TRANSPLANTATION - C2 VS CO.NEFROLOGIA. VOL. 25. ISSUE 2. P. 106-112 | 57 | 97% | 0 |
Classes with closest relation at Level 1 |